Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,154
archived clinical trials in
Osteoarthritis (OA)

Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Carlsbad, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
San Diego, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Santa Rosa, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Vista, CA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Vista, CA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Aurora, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Aurora, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Colorado Springs, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Lakewood, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Lakewood, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Littleton, CO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Littleton, CO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Clearwater, FL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Orlando, FL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Pinellas Park, FL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Atlanta, GA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Chicago, IL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Evansville, IL
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Evansville, IL
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Council Bluffs, IA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Frederick, MD
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Frederick, MD
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Worcester, MA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Edina, MN
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Edina, MN
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Saint Louis, MO
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Elkhorn, NE
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Elkhorn, NE
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Fremont, NE
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Fremont, NE
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Henderson, NV
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Henderson, NV
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Las Vegas, NV
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Jamaica, NY
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Jamaica, NY
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
New York, NY
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
High Point, NC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Raleigh, NC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Akron, OH
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Cincinnati, OH
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Columbus, OH
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Oklahoma City, OK
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Duncansville, PA
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Duncansville, PA
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Anderson, SC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Greer, SC
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Dallas, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
Houston, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Lubbock, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Lubbock, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Plano, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Plano, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Study Site
mi
from
San Antonio, TX
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Study Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  3/27/2018
Regeneron Investigational Site
mi
from
Burgas,
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 3/27/2018
Regeneron Investigational Site
mi
from
Burgas,
Click here to add this to my saved trials
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
Status: Enrolling
Updated:  3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
Status: Enrolling
Updated: 3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
Click here to add this to my saved trials
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
Assessing Catabolic Marker Levels in the Knee Synovial Fluid Microenvironment After Lavage With Platelet Poor Plasma (PPP)
Status: Enrolling
Updated:  3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
Assessing Catabolic Marker Levels in the Knee Synovial Fluid Microenvironment After Lavage With Platelet Poor Plasma (PPP)
Status: Enrolling
Updated: 3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
Click here to add this to my saved trials
Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients
A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients
Status: Enrolling
Updated:  4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients
A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients
Status: Enrolling
Updated: 4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Click here to add this to my saved trials
Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis
Status: Enrolling
Updated:  4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis
Status: Enrolling
Updated: 4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Click here to add this to my saved trials
The Strong Brain Study
A Pilot Study to Evaluate the Role of Brain Integrity on Post-hospital Sarcopenia
Status: Enrolling
Updated:  4/4/2018
Institute on Aging
mi
from
Gainesville, FL
The Strong Brain Study
A Pilot Study to Evaluate the Role of Brain Integrity on Post-hospital Sarcopenia
Status: Enrolling
Updated: 4/4/2018
Institute on Aging
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
Status: Enrolling
Updated:  4/4/2018
Dr. Samy Metyas
mi
from
Covina, CA
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
Status: Enrolling
Updated: 4/4/2018
Dr. Samy Metyas
mi
from
Covina, CA
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Campbell Clinic
mi
from
Germantown, TN
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Campbell Clinic
mi
from
Germantown, TN
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Institute for Foot and Ankle Reconstruction at Mercy
mi
from
Baltimore, MD
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Institute for Foot and Ankle Reconstruction at Mercy
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Minnesota Orthopedic Sports Medicine Institute (MOSMI)
mi
from
Edina, MN
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Minnesota Orthopedic Sports Medicine Institute (MOSMI)
mi
from
Edina, MN
Click here to add this to my saved trials
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated:  4/11/2018
Orthopaedic Associates of Michigan
mi
from
Grand Rapids, MI
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Status: Enrolling
Updated: 4/11/2018
Orthopaedic Associates of Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials